Outpatient therapy with interleukin 21 (IL-21) and Nexavar as a second or third-line therapy for metastatic renal cell cancer was associated with anti-tumor activity, with manageable side effects.
The company has reported sales of $5.94 billion for the third quarter of 2008, a decrease of 2%, compared to $6.07 billion posted in the third quarter of
Lipsovir is a patented combination of hydrocortisone (an anti-inflammatory agent) and acyclovir (an antiviral agent) in a proprietary cream base developed by Medivir. The clinical Phase III program
In the study, which assessed the maximum tolerated dose, overall safety, pharmacokinetics and preliminary efficacy of BI 6727, a total of 50 patients were treated at doses of
The expanded and updated results continued to show that picoplatin can be safely administered with full-dose docetaxel and prednisone, the standard treatment for hormone-refractory prostate cancer (HRPC), with
The trial is being carried out in patients with metastatic or unresectable solid tumors for which known effective measures do not exist or are no longer effective. In
This expanded effort will be conducted at Purdue University’s Bindley Bioscience Center, and will focus on further validating targeted, systemically delivered cancer therapies utilizing Kylin’s proprietary pRNAi platform.
Recently approved by the FDA, the Talent thoracic stent graft with the new delivery system is now available to physicians across the US. The Talent thoracic stent graft
The TomoTherapy Hi Art treatment system is said to be the only radiation therapy solution to use a CT-style ring gantry design, CT-based image guidance and two distinct
The technology will permit MDRNA to stabilize and provide drug-like properties to RISC and Dicer length small interfering RNAs (siRNAs) in a novel and proprietary manner. Terms of
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.